Lukas Ehlen

Dr. Lukas Ehlen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HKHenning Krampe
Henning Krampe
CDClaudia Denke
Claudia Denke
JGJakob Gülden
Jakob Gülden
VMVivian-Marie Mauersberger
Vivian-Marie Mauersberger
LELukas Ehlen
Lukas Ehlen
CSClaudia D Spies
Claudia D Spies
The aim of this study was to synthesize quantitative research that identified ranking lists of the most severe stressors of patients in the intensive care unit, as perceived by patients, relatives, and health care professionals (HCP). We conducted a systematic literature search in PubMed, MEDLINE, EMBASE, PsycInfo, CINAHL, and Cochrane Library from 1989 to 15 May 2020. Data were analyzed with descriptive and semi-quantitative methods to yield summarizing ranking lists of the most severe stressors. We synthesized the results of 42 prospective cross-sectional observational studies from different international regions. All investigations had assessed patient ratings. Thirteen studies also measured HCP ratings, and four studies included ratings of relatives. Data indicated that patients rate the severity of stressors lower than HCPs and relatives do. Out of all ranking lists, we extracted 137 stressor items that were most frequently ranked among the most severe stressors. After allocation to four domains, a group of clinical ICU experts sorted these stressors with good to excellent agreement according to their stress levels. Our results may contribute to improve HCPs’ and relatives’ understanding of patients’ perceptions of stressors in the ICU. The synthesized stressor rankings can be used for the development of new assessment instruments of stressors.

13 May 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LELukas Ehlen
Lukas Ehlen
JAJ. Arndt
J. Arndt
DTD. Treue
D. Treue
PBP. Bischoff
P. Bischoff
FLF. N. Loch
F. N. Loch
CKC. Kamphues
C. Kamphues
Background: Pancreatic cancer remains a fatal disease. Experimental systems are needed for personalized treatment strategies, drug testing and to further understand tumor biology. Cell cultures can serve as an excellent preclinical platform, but their generation remains challenging. Methods: Tumor cells from surgically removed pancreatic ductal adenocarcinoma (PDAC) specimens were cultured under novel protocols. Cellular growth and composition were analyzed and culture conditions were continuously optimized. Characterization of cell cultures and primary tumors was performed via hematoxylin and eosin (HE) and immunofluorescence (IF) staining. Results: Protocols for two- and three-dimensional PDAC primary cell cultures could successfully be established. Primary cell culture depended on dissociation techniques, growth factor supplementation and extracellular matrix components containing Matrigel being crucial for the transformation to three-dimensional PDAC organoids. The generated cultures showed to be highly resemblant to established PDAC primary cell cultures. HE and IF staining for cell culture and corresponding primary tumor characterization could successfully be performed. Conclusions: The work presented herein shows novel and effective methods to successfully establish primary PDAC cell cultures in a distinct time frame. Factors contributing to cell growth and differentiation could be identified with important implications for further primary cell culture protocols. The established protocols might serve as novel tools in personalized tumor therapy.

19 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AWAyk Waldow
Ayk Waldow
LBLaura-Sophie Beier
Laura-Sophie Beier
JAJanine Arndt
Janine Arndt
SSSimon Schallenberg
Simon Schallenberg
CVClaudia Vollbrecht
Claudia Vollbrecht
Joerg PiontekJoerg Piontek
Joerg Piontek
Claudins regulate paracellular permeability, contribute to epithelial polarization and are dysregulated during inflammation and carcinogenesis. Variants of the claudin-binding domain of Clostridium perfringens enterotoxin (cCPE) are highly sensitive protein ligands for generic detection of a broad spectrum of claudins. Here, we investigated the preferential binding of YFP- or GST-cCPE fusion proteins to non-junctional claudin molecules. Plate reader assays, flow cytometry and microscopy were used to assess the binding of YFP- or GST-cCPE to non-junctional claudins in multiple in vitro and ex vivo models of human and rat gastrointestinal epithelia and to monitor formation of a tight junction barrier. Furthermore, YFP-cCPE was used to probe expression, polar localization and dysregulation of claudins in patient-derived organoids generated from gastric dysplasia and gastric cancer. Live-cell imaging and immunocytochemistry revealed cell polarity and presence of tight junctions in glandular organoids (originating from intestinal-type gastric cancer and gastric dysplasia) and, in contrast, a disrupted diffusion barrier for granular organoids (originating from discohesive tumor areas). In sum, we report the use of cCPE fusion proteins as molecular probes to specifically and efficiently detect claudin expression, localization and tight junction dysregulation in cell lines, tissue explants and patient-derived organoids of the gastrointestinal tract.

26 July 2024 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LELukas Ehlen
Lukas Ehlen
MSMichael Schmueck-Henneresse
Michael Schmueck-Henneresse

10 March 2026 in Molecular Therapy Oncology
Verified
Journal Article
Open access
MFMartí Farrera-Sal
Martí Farrera-Sal
LELukas Ehlen
Lukas Ehlen
MSMichael Schmueck-Henneresse
Michael Schmueck-Henneresse